When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Prior to Collegium Pharmaceutical’s (COLL) Q3 earnings report, most people wouldn’t classify 2019 as a breakthrough year for the company. Collegium has made significant headway towards hitting its 2019 goals and is now positioned to be one of the leaders in responsible pain management. Most notably is the company’s continued formulary wins including numerous exclusive formulary positions for Xtampza ER. This news was recently announced in the company’s Q3 earnings report and the market reacted positively with the share price rising almost 50% in the subsequent trading days (Figure 1). It looks